Dr. Neil MacIntyre (Chairman) is Chief of Clinical Services, Department of Pulmonary Medicine at Duke University Medical Center. Dr. MacIntyre is world renowned and respected in the field of pulmonary medicine and has several publications in the field of aerosol research and COPD.

Dr Paul O’Byrne is the EJ Moran Campbell Professor and Chairman of the Department of Medicine of the De Groote school of Medicine at McMaster University in Hamilton, Ontario Canada. He has published more than 300 peer reviewed studies in important journals and has edited and contributed chapters to almost 100 books.

Dr. Christopher B. Cooper, M.D. is Professor of Medicine and Physiology and Medical Director, Chronic Obstructive Pulmonary Disease Program at UCLA’s division of pulmonary medicine. Dr. Cooper is a leading expert in the field of COPD and has several publications to his credit.

Professor Chris O’Callaghan is one of the Europe’s leading pediatric pulmonologists and has recently been chosen to head the Portex Unit at the UCL Great Ormond St pediatric hospital, Institute of Child Health. He is author or co-author of 15 books and has published more than 120 studies in highly-rated peer-reviewed journals including ‘Nature’.

Dr. James F. Donohue, is Professor of Medicine (post tenure review 2001) at the University of North Carolina, School of Medicine, Department of Medicine in Chapel Hill. Presently he is the Division Chief of Pulmonary Diseases and Critical Care Medicine. He previously served as Vice Chairman of Clinical Services, Department of Medicine and Clinical Director of the Pulmonary Diseases and Critical Care Division. Dr. Donohue advises several pharmaceutical companies on their clinical and regulatory strategies.

Dr. Martin Kolb is associate professor of internal medicine and respirology and is head of research at the Firestone Institute. He is a clinician-scientist with an international reputation in the area of lung injury and fibrosis because of his intense interest in the causes, mechanisms and therapy of fibrotic conditions of the lungs.

Dr. Bruce Rubin is the Jessie Ball duPont Distinguished Professor and Chair Department of Pediatrics at VCU. Dr. Rubin is a pediatric pulmonary expert and is on the editorial board of 12 pulmonary journals, has published more than 200 research papers and chapters and holds five patents. His specific clinical research interests include cystic fibrosis, childhood asthma and other chronic lung diseases.

Dr. Gerald Smaldone is a Professor of Medicine, Physiology and Biophysics at the State University of New York at Stony Brook. Since 1980, he has been at Stony Brook as a member of the Pulmonary, Critical Care and Sleep Division, Department of Medicine. His research activities include a long-standing interest in pulmonary mechanics, the use of aerosols as special tools to study respiratory behavior and the development of better techniques for aerosolized drug delivery.

Dr. Stuart Stoloff is a Clinical Professor in the Department of Family and Community Medicine at the University of Nevada School of Medicine. He is a Fellow of both the American Academy of Allergy, Asthma and Immunology and the American Academy of Family Physicians. He was the recipient of the Special Service Award 2000 of the American Academy of Allergy, Asthma and Immunology and named Nevada Family Physician of the year in 1997.

Dr. Fiel-5.jpeg

Stanley B. Fiel, MD, FACP, FCCP

Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University Regional Chairman, Department of Medicine/Atlantic Health System, The deNeufville Professor and Chairman, Department of Medicine, Morristown Medical Center

Stanley B. Fiel, MD, Regional Chairman of Medicine, Morristown Medical Center, is a distinguished physician and author of numerous published works on various topics relating to pulmonary and critical care medicine.

After receiving a Bachelor of Science degree from the University of Connecticut, Dr. Fiel was awarded his Medical Degree and inducted into Alpha Omega Alpha honor society at the Medical College of Pennsylvania in Philadelphia. He then completed an internship and residency at Temple University Hospital in Philadelphia and a fellowship in the pulmonary disease section of the Hospital of the University of Pennsylvania. Since 1978, Dr. Fiel has held key hospital appointments including Chief of the Division of Pulmonary/Critical Care Medicine at Drexel University College of Medicine and Hahnemann University in Philadelphia.

A Fellow of the American College of Chest Physicians and the American College of Physicians, Dr. Fiel also is a member of the American Thoracic Society and other professional societies. He currently serves or has served previously on the editorial boards for journals such as the Journal of Asthma, Chest, and Clinical Pulmonary Medicine. Dr. Fiel's many contributions to medical literature have appeared in publications such as The New England Journal of Medicine, the Journal of the American Medical Association, the American Journal of Respiratory and Critical Care Medicine, and Chest. His major research interests include the mechanisms of inflammation in cystic fibrosis and therapeutic advances in the treatment of obstructive pulmonary disorders including asthma, cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.  He has published more than 150 articles in the Medical literature.

Dr. Fiel currently serves on the Advisory Board and Speaker’s Bureau with Pfizer, GlaxoSmithKline, Gilead and Novartis.  He has been a consultant for GlaxoSmithKline, Novartis, Pfizer, Gilead and Vertex.  He has received research grants from the NIH, Cystic Fibrosis Foundation and various pharmaceutical companies

Carlos Carmargo

Bio forthcoming


Tonya Winders, MBA

Tonya Winders. MBA is currently the President and Chief Executive Officer of Allergy & Asthma Network, the leading patient advocacy organization dedicated to ending the needless death and suffering due to asthma, allergies and related conditions.

Tonya has over 18 years experience in leadership roles within the allergy and asthma industry. From sales and marketing leadership to managed markets access, she has worked tirelessly to ensure patients have access to effective diagnostic and treatment tools.

Tonya serves on several expert panels including the ATS Public Advisory Roundtable & the GINA/GOLD guidelines as the patient reviewer.  Furthermore, she is on the board of directors for Not One More Life, American Respiratory Care Foundation and is the current president of the Global Allergy Asthma Patient Platform, representing more than 40 patient organizations throughout the world.

Personally, Tonya is the mother of five children, four of whom have asthma and/or allergies, ranging in age from 14-20 years old.  She enjoys spending time with her husband of 23 years Brian Winders and cheering on her children in various sports.